On September 30, Gracealliance reported that Sisram Med (01696.HK) announced the establishment of a new direct sales business channel in Thailand. The direct sales channel will start with injection filling business as the company's exclusively represented injection filling product Profhilo has been approved by the Thai Food and Drug Administration, and they look forward to registering more products in the future to optimize customer experience and selection.
The company has been actively seeking to expand its direct sales business in strategically appropriate markets, to enhance interaction with customers, strengthen the stickiness with customers and consumers, and increase brand awareness. Thailand is a continuously growing and dynamic market in the global beauty industry, and an important emerging economy in Southeast Asia.
Therefore, the company believes that by promoting the company's comprehensive beauty and health ecosystem products and innovative products in Thailand, it will bring exciting long-term growth opportunities for the brand and business in the region and even globally. This will bring the greatest return to shareholders and benefit both the company and its shareholders.
